Active Ingredient
(in each extended-release tablet)
Guaifenesin USP 1200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Aurohealth Llc for the product Guaifenesin (NDC 58602-865). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each extended-release tablet)
Guaifenesin USP 1200 mg
Expectorant
Do not use
ask a health professional before use
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, and pregelatinised starch (maize)
1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)
Distributed by:
AUROHEALTH LLC.
279 Princeton-Hightstown Road
East Windsor, NJ 08520
Made in India
NDC 58602-865-03
PrimaryHealth
COMPARE TO Maximum Strength Mucinex®
Active Ingredient*
MAXIMUM STRENGTH
Guaifenesin
Extended-Release Tablets
1200 mg
Guaifenesin 1200 mg – Expectorant
RELIEVES CHEST CONGESTION
12
HOUR
Actual size
42
Extended-Release
Tablets
* Please review the disclaimer below.